Early vs late catheter removal after Acute urinary retention

A Randomized Control Trial of Early Versus Late Catheter Removal in Patients with Acute Urinary Retention Secondary to Benign Prostatic Hyperplasia Receiving Tamsulosin

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045505

Enrollment

200

Registered

2022-09-14

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Early catheter removal: Tamsulosin 0.4 mg will be given once daily to patients, and the catheter is withdrawn after one day. Control Intervention1: Late catheter removal: Tamsulosin 0.4

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients > 50 years. 2. Written informed consent. 3. Patients presented with AUR due to BPH

Exclusion criteria

Exclusion criteria: 1. Patients with initial catheterization volume >1000 ml 2. Bladder stones 3. Renal impairment 4. Suspected urethral stricture 5. Neurogenic bladder 6. Cancer prostate 7. Medically induced retention 8. Previous use of alpha-blockers 9. Chronic retention 10. Hydroureteronephrosis on ultrasonography (USG)

Design outcomes

Primary

Measure	Time frame
Trial without catheter after 1 day vs. 7 days of alpha blocker (Tamsulosin) therapy in patients with AUR secondary to BPH.Timepoint: Trial without catheter after 1 day vs. 7 days of alpha blocker (Tamsulosin) therapy in patients with AUR secondary to BPH.	—

Secondary

Measure	Time frame
Catheter related complicationsTimepoint: At the time of catheter removal;HPR (Histopathological reports) in patients that have undergone TURP after failed TWOCTimepoint: After Surgery;Serum PSATimepoint: At patient presentation	—

Countries

India

Contacts

Public ContactSwarnendu Mandal

AIIMS Bhubaneswar

urol_swarnendu@aiimsbhubaneswar.edu.in8447562972

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026